CombiMatrix, Arizona State work on peptide array synthesizer

Aug. 12, 2005 — Acacia Research Corp. (NASDAQ: CBMX) (NASDAQ: ACTG) announced that its CombiMatrix group and the Biodesign Institute at Arizona State University are collaborating toward the development of a peptide array synthesizer utilizing CombiMatrix’s proprietary virtual-flask technology.

Under the agreement, the Biodesign Institute’s Center for BioOptical Nanotechnology is purchasing CombiMatrix equipment and funding development of the synthesizer. CombiMatrix is granting technology rights and contributing expertise related to CombiMatrix technology. CombiMatrix and the Institute will share revenue from commercialization of the peptide array synthesizer, peptide array products, and intellectual property that are developed.

The collaboration is aimed at developing a peptide synthesizer that will build arrays of polypeptides on CombiMatrix CustomArrays. Such arrays are useful in areas such as immunology research, drug discovery, and diagnostics.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.